Article Details
Retrieved on: 2021-07-05 08:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... global collaboration with Alector to develop and commercialise two monoclonal antibodies (mAb) for the treatment of neurodegenerative diseases.
Article found on: www.pharmatimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here